Effect of Statins, Angiotensin-Converting Enzyme Inhibitors, and Beta Blockers on Survival in Patients ≥65 Years of Age With Heart Failure and Preserved Left Ventricular Systolic Function-Reference-Cited by-同舟云学术

Effect of Statins, Angiotensin-Converting Enzyme Inhibitors, and Beta Blockers on Survival in Patients ≥65 Years of Age With Heart Failure and Preserved Left Ventricular Systolic Function

Published:2008-01 Issue:2 Volume:101 Page:217-222
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Shah Rahman,Wang Yung,Foody JoAnne M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Statin use and survival outcomes in elderly patients with heart failure;Ray;Arch Intern Med,2005

2. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure;Horwich;J Am Coll Cardiol,2004

3. Statin therapy and risks for death and hospitalization in chronic heart failure;Go;JAMA,2006

4. Statins and mortality among elderly patients hospitalized with heart failure;Foody;Circulation,2006

5. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives;International Journal of Molecular Sciences;2024-05-01

2. Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review;American Journal of Cardiovascular Drugs;2024-04-04

3. Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): A systematic review and meta-analysis;Current Problems in Cardiology;2024-03

4. Systematic review and meta-analysis of the association between all-cause mortality and statin therapy in patients with preserved ejection fraction heart failure (HFpEF);International Journal of Cardiology;2023-02

5. Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study;BMC Cardiovascular Disorders;2022-03-23